Amraotkar, A.R.; Bushau-Sprinkle, A.M.; Keith, R.J.; Hamorsky, K.T.; Palmer, K.E.; Gao, H.; Rai, S.N.; Bhatnagar, A.
Pre-Existing Comorbidities Diminish the Likelihood of Seropositivity after SARS-CoV-2 Vaccination. Vaccines 2022, 10, 1363.
https://doi.org/10.3390/vaccines10081363
AMA Style
Amraotkar AR, Bushau-Sprinkle AM, Keith RJ, Hamorsky KT, Palmer KE, Gao H, Rai SN, Bhatnagar A.
Pre-Existing Comorbidities Diminish the Likelihood of Seropositivity after SARS-CoV-2 Vaccination. Vaccines. 2022; 10(8):1363.
https://doi.org/10.3390/vaccines10081363
Chicago/Turabian Style
Amraotkar, Alok R., Adrienne M. Bushau-Sprinkle, Rachel J. Keith, Krystal T. Hamorsky, Kenneth E. Palmer, Hong Gao, Shesh N. Rai, and Aruni Bhatnagar.
2022. "Pre-Existing Comorbidities Diminish the Likelihood of Seropositivity after SARS-CoV-2 Vaccination" Vaccines 10, no. 8: 1363.
https://doi.org/10.3390/vaccines10081363
APA Style
Amraotkar, A. R., Bushau-Sprinkle, A. M., Keith, R. J., Hamorsky, K. T., Palmer, K. E., Gao, H., Rai, S. N., & Bhatnagar, A.
(2022). Pre-Existing Comorbidities Diminish the Likelihood of Seropositivity after SARS-CoV-2 Vaccination. Vaccines, 10(8), 1363.
https://doi.org/10.3390/vaccines10081363
